Great Diamond Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $376K | Sell |
928
-122
| -12% | -$49.5K | 0.08% | 166 |
|
2025
Q1 | $522K | Sell |
1,050
-63
| -6% | -$31.3K | 0.14% | 114 |
|
2024
Q4 | $579K | Sell |
1,113
-91
| -8% | -$47.3K | 0.15% | 108 |
|
2024
Q3 | $745K | Sell |
1,204
-420
| -26% | -$260K | 0.19% | 99 |
|
2024
Q2 | $898K | Buy |
1,624
+24
| +2% | +$13.3K | 0.21% | 98 |
|
2024
Q1 | $930K | Buy |
1,600
+25
| +2% | +$14.5K | 0.21% | 100 |
|
2023
Q4 | $836K | Buy |
1,575
+164
| +12% | +$87.1K | 0.21% | 100 |
|
2023
Q3 | $714K | Buy |
1,411
+411
| +41% | +$208K | 0.19% | 107 |
|
2023
Q2 | $522K | Sell |
1,000
-4
| -0.4% | -$2.09K | 0.14% | 128 |
|
2023
Q1 | $579K | Sell |
1,004
-6
| -0.6% | -$3.46K | 0.17% | 119 |
|
2022
Q4 | $556K | Sell |
1,010
-14
| -1% | -$7.71K | 0.17% | 112 |
|
2022
Q3 | $519K | Sell |
1,024
-9
| -0.9% | -$4.56K | 0.18% | 112 |
|
2022
Q2 | $561K | Buy |
1,033
+27
| +3% | +$14.7K | 0.19% | 105 |
|
2022
Q1 | $594K | Buy |
1,006
+7
| +0.7% | +$4.13K | 0.17% | 110 |
|
2021
Q4 | $666K | Buy |
999
+77
| +8% | +$51.3K | 0.17% | 110 |
|
2021
Q3 | $526K | Buy |
+922
| New | +$526K | 0.14% | 117 |
|
2021
Q2 | – | Sell |
-513
| Closed | -$234K | – | 202 |
|
2021
Q1 | $234K | Buy |
513
+5
| +1% | +$2.28K | 0.07% | 176 |
|
2020
Q4 | $236K | Buy |
508
+14
| +3% | +$6.5K | 0.08% | 162 |
|
2020
Q3 | $218K | Buy |
+494
| New | +$218K | 0.08% | 152 |
|
2020
Q1 | – | Sell |
-570
| Closed | -$185K | – | 556 |
|
2019
Q4 | $185K | Buy |
+570
| New | +$185K | 0.07% | 157 |
|